Stocktwits on MSN
Lupin Gains On FDA Nod For HIV Drug; Technicals Suggest Potential Upside Above ₹2,060
Lupin shares climbed on Thursday after the U.S. Food and Drug Administration gave a tentative approval to the company to sell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback